Deal management for Life Sciences
airSlate SignNow regularly wins awards for ease of use and setup
See airSlate SignNow eSignatures in action
Our user reviews speak for themselves
Why choose airSlate SignNow
-
Free 7-day trial. Choose the plan you need and try it risk-free.
-
Honest pricing for full-featured plans. airSlate SignNow offers subscription plans with no overages or hidden fees at renewal.
-
Enterprise-grade security. airSlate SignNow helps you comply with global security standards.
Deal management for Life Sciences
Deal management for Life Sciences
Experience the benefits of using airSlate SignNow for deal management in the Life Sciences industry today. Simplify your processes, increase efficiency, and ensure compliance with ease.
Sign up for a free trial now and see how airSlate SignNow can transform your deal management workflow!
airSlate SignNow features that users love
Get legally-binding signatures now!
FAQs online signature
-
What is the deal governance process?
Deal governance is best characterized as a methodical approach that encompasses the protocols, procedures, and directives governing how an organization assesses, negotiates, executes, and oversees strategic transactions.
-
What is the difference between CRM and deal management?
Deal Relationship Management (DRM) solutions are designed explicitly for managing the intricacies of individual deals. Unlike CRM systems, DRMs are more focused and streamlined, addressing the specific needs of deal-oriented businesses across various asset classes, regardless of industry or market segment.
-
What is deal management?
What is deal management? Deal management is the strategy of executing deal workflows and establishing deal parameters. These parameters can include customer history, operational constraints, team member roles, product status, and more.
-
What is the meaning of deal management?
Deal management is the sales operations process of overseeing and coordinating all aspects of a deal, from start to finish. This includes identifying and pursuing opportunities, negotiating terms, and ensuring that all parties involved are satisfied with the outcome.
-
What is deal management in Oracle?
Oracle's PeopleSoft Deal Management is essential to liquidity management, improving investment returns and reducing interest expense while improving the productivity of your staff. Our solution offers streamlined deal initiation, administration, settlement accounting, and position monitoring.
Trusted e-signature solution — what our customers are saying
How to create outlook signature
(upbeat electronic music) - There is a mega trend, we have aging demographics, so there's need for more medicines. At the same time, the combination of big data and genomics is creating a whole world of potential medicines. And what that means is there's huge need for capital. - Blackstone Life Sciences is a new business at Blackstone. It came about by the acquisition of Clarus, the investment firm in the life sciences that my partners and I founded 15 years ago. The business model is: invest in products that have a high probability of approval. We work with pharmaceutical and biotechnology companies to source these products, then work with them to design a trial and get the product approved. - Everything starts with the molecule. What we know about it, it's underlying biology, the science. And from that we can build on the clinical trials bringing that molecule to patients. - [Nick] Scale is extremely important in our sector. With scale, we can continue investing in our most promising companies and products to see them all the way through to approval and eventual commercialization. - Trial design really is what you're proving that your product and therapy can add to make a patient's life better. - Having a dedicated, focused team with huge experience in the area, as well as contract research organizations means that you're actually looking at a higher percentage chance of success for a study. We're making sure they've got a track record, they've got the time, the resources to run a clinical trial, and actually the quality will be good. - If you take a look at the pharm industry as a whole, for late stage clinical development regulatory approval, the success rate is about 60%. If you take a look at ours, ours is approaching 90%. - We want to be the industry's preferred partner and offer financing solutions to the pharmaceutical industry, the technology industry and the medical technology industry. - To be able to impact a heart patient's life, to be able to help cancer patients, to accelerate drug development. It's a very special feeling to know that this business is an important part of Blackstone. (upbeat pop music)
Show more